International Journal of Medical Laboratory Research (IJMLR)

MORPHOPATHOLOGY OF PANCREAS IN DIABETES MELLITUS- A PROSPECTIVE STUDY DONE IN 50 AUTOPSY CASES

​

S Rani ,VK Bodal , AK Aggarwal, B Rani

 

ABSTRACT: The pancreas comprises exocrine and endocrine compartments, with the latter comprising the pancreatic islet with its endocrine cells. In both type1 and type2 diabetes, several morphological changes occur in the pancreas, but the predominant feature of beta cell loss. Our aim of this study is to find out of histopathological changes in pancreas due to diabetes and correlate it with clinical findings. Methods: A prospective study was done on 50 autopsy specimens of pancreas. Specimens were fixed in formalin and tissue was adequately processed. The sections were stained with routine haematoxylene and eosin stain. Results: In our study 86% cases were of T1DM and 14% of T2DM. Most common age group was between 40-60 years (62% cases). 68% cases had duration of DM of 10-20 years. On histopathological examination, 85% Cases of T1DM revealed cytolysis and inflammation in exocrine pancreas. In cases of T2DM cytolysis was seen in 32% cases, inflammation in 25% and fibrosis in 16% cases.. Fibrosis was present in 14% cases of T1DM and 25% cases of T2DM in endocrine pancreas. Insulitis in endocrine pancreas was seen in 85% cases of T1DM and 34% cases of T2DM. Thus, the most common finding was reduced beta cell mass in T2DM and insulitis in T1DM. Findings were correlated with age, sex and duration of diabetes. Conclusion: With increasing incidence of diabetes knowledge of pathogenesis of changes due to diabetes in pancreas may lead to research of further targeted therapy in better management of diabetes in future. Changes that occur in pancreas due to diabetes are more evident in long standing diabetes and early changes are not evident in routine histopathological sections.

 

KEY WORDS: diabetes mellitus, endocrine pancreas, exocrine pancreas, beta cell mass, insulitis, fibrosis

​

REFERENCES:

1. Longnecker DS. Anatomy and Histology of the Pancreas. Pancreapedia: The Exocrine Pancreas Knowledge Base. 2014 Mar20 p1-26.

2. Hellman B. Actual distribution of the number and volume of the islets of Langerhans in different size classes in non-diabetic humans of varying ages. Nature 1959:184(Suppl 19): 1498-1499.

3. Johnson KH, O'Brien TD, Betsholtz C, Westermark P. Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus. N Engl J Med. 1989;321(8):513-8.

4. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes. 1965;14(10):619-33.

5. Löhr M, Klöppel G. Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin-dependent) diabetes mellitus and microangiopathy. Diabetologia. 1987;30:757–762.

6. Deng S, Vatamaniuk M, Huang X, Doliba N, Lian MM, Frank A et al.Structural and funtional abnormalities in the islets isolated from type 2 diabetic subjects. 2004;53(3):624-32.

7. Rahier J, Guiot Y, Goebbels RM, Sempoux C, Henquin JC. Pancreatic β‐cell mass in European subjects with type 2 diabetes. Diabetes ObesMetab. 2008;10(s4):32-42.

8. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS. The histopathology of the pancreas in type I (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia. 1986;29(5):267-74.

9. Bottazzo GF. β-Cell damage in diabetic insulitis: are we approaching a solution?. Diabetologia. 1984;26(4):241-9.

10. Krogvold L, Wiberg A, Edwin B, Buanes T, Jahnsen FL, Hanssen KF et al.Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes. Diabetologia. 2016;59(3):492-501.

11. Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S. Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese Type II diabetic patients. Diabetologia. 2002;45(1):85-96.

12. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52 (1):102-10.